Stock ARCOMA ARCOMA AB
Add to a list
To use this feature you must be a member
Log inSign up

Ratings Arcoma AB

Equities

ARCOMA

SE0006219176

Delayed Nasdaq Stockholm
Other stock markets
 08:39:31 2024-04-26 am EDT 		5-day change 1st Jan Change
13.65 SEK +3.80% Intraday chart for Arcoma AB +17.67% +71.70%
Apr. 25 Arcoma AB Reports Earnings Results for the First Quarter Ended March 31, 2024 CI
Jan. 29 Arcoma AB Reports Earnings Results for the Full Year Ended December 31, 2023 CI

Summary

  • The company has strong fundamentals. More than 70% of companies have a lower mix of growth, profitability, debt and visibility.

Strengths

  • The earnings growth currently anticipated by analysts for the coming years is particularly strong.
  • With regards to fundamentals, the enterprise value to sales ratio is at 0.95 for the current period. Therefore, the company is undervalued.
  • Over the past year, analysts have regularly revised upwards their sales forecast for the company.
  • Growth remains a strong point in this company. In their sales forecast, analysts sound optimistic with regard to sales prospects.

Weaknesses

  • The valuation of the company is particularly high given the cash flows generated by its activity.
  • The company's earnings releases usually do not meet expectations.

Ratings chart - Surperformance

Sector: Advanced Medical Equipment & Technology

1st Jan change Capi. Investor Rating ESG Refinitiv
ARCOMA AB Stock Arcoma AB
+71.70% 15.9M -
SHANGHAI UNITED IMAGING HEALTHCARE CO., LTD. Stock Shanghai United Imaging Healthcare Co., Ltd.
-7.02% 14.49B -
IRAY TECHNOLOGY COMPANY LIMITED Stock iRay Technology Company Limited
-39.19% 2.78B
C-
SONOSCAPE MEDICAL CORP. Stock SonoScape Medical Corp.
-13.76% 2.42B -
BEIJING WANDONG MEDICAL TECHNOLOGY CO.,LTD. Stock Beijing Wandong Medical Technology Co.,Ltd.
-11.53% 1.47B - -
CORETAG, INC. Stock Coretag, Inc.
-.--% 1.12B - -
NANO-X IMAGING LTD. Stock Nano-X Imaging Ltd.
+40.03% 515M -
DETECTION TECHNOLOGY OYJ Stock Detection Technology Oyj
+13.14% 233M
C
VIEWORKS CO., LTD. Stock Vieworks Co., Ltd.
+1.11% 183M -
INTROMEDIC CO., LTD. Stock IntroMedic Co., Ltd.
-.--% 168M - -
Investor Rating
Trading Rating
ESG Refinitiv
-

Financials

Sales growth
Earnings Growth
EBITDA / Sales
Profitability
Finances

Valuation

P/E ratio
EV / Sales
Price to Book
-
Price to Free Cash Flow
Yield
-

Momentum

1 year Revenue revision
4 months Revenue revision
7 days Revenue revision
1 year EPS revision
4 months EPS revision

Consensus

Analyst Opinion
Potential Price Target
4m Target Price Revision
4m Revision of opinion
-
12m Revision of opinion
-

Business Predictability

Analyst Coverage
Divergence of Estimates
-
Divergence of analysts' opinions
-
Divergence of Target Price
-
Earnings quality
  1. Stock Market
  2. Equities
  3. ARCOMA Stock
  4. Ratings Arcoma AB